University of Kinshasa Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Kinshasa Uganda (1954)

Organization Overview

First Clinical Trial
2007
NCT00538382
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Kinshasa School of Public Health | Kinshasa University | Kinshasa University, RDCongo | Université de Kinshasa | University of Kinshasa | University of Kinshasa, Kinshasa, Democratic Republic of Congo | University of Kinshasa, Tropical Medicine Department

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Cervical Intraepithelial Neoplasia (Phase 3)

Communicable Diseases (Phase 4)

Death (Phase 3)

Hemorrhagic Fever, Ebola (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Infections (Phase 4)

Malaria (Phase 4)

Maternal Death (Phase 3)

Monkeypox (Phase 3)

Neonatal Sepsis (Phase 3)

Papillomavirus Infections (Phase 3)

Perinatal Death (Phase 3)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Sepsis (Phase 3)

Smallpox (Phase 3)

Toxemia (Phase 3)

Uterine Cervical Dysplasia (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 30